NCT03536091View on ClinicalTrials.gov

Magnification Endoscopy and Electronic Chromoendoscopy in Patients With Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

June 1, 2018

Study Completion Date

July 1, 2018

Conditions
Inflammatory Bowel Diseases
Interventions
DIAGNOSTIC_TEST

Magnification endoscopy

All IBD patients will undergo magnification endoscopy with 136-fold optical magnification in conjunction with optical chromoendoscopy

Trial Locations (1)

91054

University Hospital Erlangen, Erlangen

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER

NCT03536091 - Magnification Endoscopy and Electronic Chromoendoscopy in Patients With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter